Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

4 treatments under study, led by Levonorgestrel

Research Leaders

7 sponsors active, led by Unity Health Toronto

Related Conditions

Often studied with 10 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 37/100

Termination Rate

0.0%

0 terminated out of 4 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed with results

Key Signals

1 with results100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Completed2
Recruiting1
Enrolling By Invitation1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (4)

Research Network

Common Treatments

  • Levonorgestrel1
  • Educational Webinar And Resources1
  • Semaglutide1
  • Survey Using A Questionnaire1

Active Sponsors

  • Unity Health Toronto1
  • Applied Health Research Centre1
  • Canadian Cancer Society (CCS)1
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)1
  • Cliniques universitaires Saint-Luc- Université Catholique de Louvain1

Top Investigators

Related Conditions

  • Educational Intervention1
  • Breast Cancer1
  • Endometrial Cancer1
  • Young Adult Cancer1
  • Decision Aid1

Activity Timeline